SCHEMBL6836651

SCHEMBL6836651

C=CCC(C(C)=O)C(=O)CC

nearest known ligand 0.36

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.36
TSHR P16473 1/20 0.36
TDP1 Q9NUW8 1/20 0.32
GRIK1 P39086 2/20 0.31
GRIK2 Q13002 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28512848 0.89 TSHR (0.40) ALDH1A1TSHRTDP1GRIK1GRIK2
SCHEMBL10546961 0.84 GRIK1 (0.39) ALDH1A1TSHRTDP1GRIK1GRIK2
SCHEMBL1973010 0.84 GRIK1 (0.40) ALDH1A1TSHRGRIK1GRIK2
SCHEMBL28236165 0.83 TSHR (0.34) ALDH1A1TSHR
SCHEMBL30979219 0.81 GRIK1 (0.39) ALDH1A1TSHRGRIK1GRIK2
SCHEMBL30979220 0.81 GRIK1 (0.39) ALDH1A1TSHRGRIK1GRIK2
SCHEMBL12819221 0.80 ALDH1A1 (0.33) ALDH1A1TDP1
SCHEMBL31585 0.79 GRIK1 (0.42) ALDH1A1GRIK1GRIK2
SCHEMBL17578458 0.78 ALDH1A1 (0.35) ALDH1A1TSHR
SCHEMBL19284346 0.78 SOAT1 (0.37) ALDH1A1TSHRTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112300338-B Modified ester polycarboxylate superplasticizer and preparation method thereof 科之杰新材料集团有限公司 2022-04-29 CN disclosed
CN-112300339-A Modified ether polycarboxylic acid water reducing agent and preparation method thereof 科之杰新材料集团有限公司 2021-02-02 CN disclosed
CN-112300338-A Modified ester polycarboxylate superplasticizer and preparation method thereof 科之杰新材料集团有限公司 2021-02-02 CN disclosed
US-20040086747-A1 Azepine compounds DAICEL CHEMICAL INDUSTRIES, LTD. (JP) 2004-05-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040086747-A1 Azepine compounds AZI2, CHRM1, CPNE4 ALDH1A1 540/4885TSHR 3086/4885TDP1 3401/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.